OFIX stock forecast
Our latest prediction for Orthofix Medical, Inc.'s stock price was made on the Aug. 28, 2019 when the stock price was at 50.88$.
In the short term (2weeks), OFIX's stock price should outperform the market by 0.82%. During that period the price should oscillate between -4.41% and +5.17%.
In the medium term (3months), OFIX's stock price should outperform the market by 2.48%. During that period the price should oscillate between -11.17% and +15.93%.Get email alerts
About Orthofix Medical, Inc.
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
At the moment the company generates 458M USD in revenues.
On its last earning announcement, the company reported a profit of 0.42$ per share.
The book value per share is 16.91$
Three months stock forecastAug. 28, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|